Regeneron’s gene therapy for otoferlin-related hearing loss – a genetic cause of deafness – has restored hearing to normal levels in one profoundly deaf child within just 24 weeks. The result comes ...
French biotech Sensorion has filed its first regulatory application to start human testing of OTOF-GT, a gene therapy for one of the most common forms of congenital deafness. The therapy is designed ...
The design of the Band I and Band II transmitting aerials for the Ashkirk station has been based on theoretical predications and model measurements which are described in this report. The aerials are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback